Dr. Brazg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
723 Sw 10th St
Ste 250
Renton, WA 98057Phone+1 425-656-4040Fax+1 425-656-4046
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1992
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1987 - 1990
University of the WitwatersrandClass of 1980
Certifications & Licensure
WA State Medical License 1990 - 2025
MI State Medical License 1989 - 1993
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011
- Super Doctor SuperDoctors.com
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use Start of enrollment: 2011 Nov 01
- In Clinic Evaluation of the PLGM Feature Start of enrollment: 2014 Oct 01
- Adult Accuracy Study of the Enlite 3 Glucose Sensor Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsComparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems.Manuel Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy S Bailey, Lia Bally
Diabetes Technology & Therapeutics. 2024-04-01 - 15 citationsAccuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System.Shridhara Alva, Ronald Brazg, Kristin Castorino, Mark Kipnes, David R Liljenquist
Diabetes Therapy. 2023-04-01 - 20 citationsImproved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.Satish K Garg, George Grunberger, Ruth Weinstock, Margaret L Lawson, Irl B Hirsch
Diabetes Technology & Therapeutics. 2023-01-01
Press Mentions
U.S. Pivotal Trial Starts for Senseonics Glucose Monitor Implant with Data Due in JuneJanuary 21st, 2016
Senseonics Announces Start of PRECISE II U.S. Trial of Long-Term CGMJanuary 20th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
